| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 07/13/2020 | 3. Issuer Name and Ticker or Trading Symbol At Home Group Inc. [ HOME ] | |||||||||||||
| 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 1,211(1) | D | |
| Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Employee Stock Option (Right to Buy) | (2) | 04/01/2026 | Common Stock | 8,719 | 18.61 | D | |
| Employee Stock Option (Right to Buy) | (3) | 09/12/2026 | Common Stock | 3,950 | 8.95 | D | |
| Employee Stock Option (Right to Buy) | (4) | 06/22/2027 | Common Stock | 22,500 | 7.58 | D | |
| Explanation of Responses: |
| 1. This amount includes 896 shares deliverable upon vesting of restricted stock units. The restricted stock units were granted to the reporting person on April 1, 2019 and, subject to the reporting person's continued employment with the issuer, will vest in substantially equal installments on each of April 1, 2021 and April 1, 2022 and be settled in shares of common stock within 30 days thereafter. |
| 2. This option is vested with respect to 2,907 of the underlying shares and, subject to the reporting person's continued employment with the issuer through the applicable vesting date, this option is scheduled to vest with respect to 5,812 of the underlying shares in substantially equal installments on each of April 1, 2021, and April 1, 2022. |
| 3. Subject to the reporting person's continued employment with the issuer through the applicable vesting date, this option is scheduled to vest in substantially equal installments on each of September 12, 2020, September 12, 2021, and September 12, 2022. |
| 4. Subject to the reporting person's continued employment with the issuer through the applicable vesting date, this option is scheduled to vest in substantially equal installments on each of June 22, 2021, June 22, 2022, and June 22, 2023. |
| /s/ Mary Jane Broussard, Attorney-in-Fact for Laura L. Bracken | 07/13/2020 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
